Five Visionary CEOs Share How AI and Digital Will Shape Our Future
Forbes contributing writer Robert Reiss recently interviewed five forward-thinking CEOs whose companies are transforming their fields: Graham Gardner, M.D., Co-founder and CEO of Kyruus; Jim Barnett, Co-founder, CEO, and Chairman of Glint; Lixin Cheng, CEO of ZTE Mobile Devices; Andy Ory, Co-founder and CEO of 128 Technology; and Rich Riley, CEO of Shazam.
Gardner took the opportunity to discuss the healthcare industry and Kyruus’ role in transforming and disrupting it. “While healthcare is a field known for scientific breakthroughs that can transform patients’ lives, it often lags behind other industries when it comes to the adoption of workflow best practices,” he said, noting that while the healthcare industry produces a lot of data, it has historically not done well at utilizing that data.
With the emergence of Big Data and the passage of the Affordable Care Act came an urgent need to understand and manage provider networks oriented around value-based care. Kyruus now houses tens of millions of data points on more than 100,000 providers and helps health systems across the U.S. to make patient-provider matches based on clinical expertise, insurance, demographics, availability, and more.
Gardner said healthcare as an industry has lost productivity during an era when technological advances are improving productivity in other sectors, primarily because healthcare relies on people and manual processes. It’s crucial that technology not harm the provider-patient relationship, but some low-yield tasks in health system call centers, for example, could be offloaded onto chatbots in order to leverage the human element for those situations still requiring it. This would enable consumers to start with digital engagement and transition to a human interaction at the appropriate point.
Kyruus, a McKesson Ventures portfolio company, provides enterprise software solutions that enable hospitals and health systems to optimize the patient experience across all channels of patient access.
To read more of Gardner’s insights, plus those of the four other CEOs interviewed, please read this article on Forbes.